Received Nov 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Wrong schedule; Rash around her neck, armpits and under breast; This non-serious case was reported by a consumer via call center representative and described the occurrence of rash in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: Rash around her neck, armpits and under breast) and incomplete course of vaccination (Verbatim: Wrong schedule). The outcome of the rash was resolved (duration 3 days) and the outcome of the incomplete course of vaccination was not applicable. The reporter considered the rash to be unrelated to Shingrix. The company considered the rash to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 20-NOV-2025 The patient self-reported this case for herself. The patient mentioned that she had received her first Shingrix vaccine when it first became available. The patient stated that she did not go back for the second dose in the series. The reporter stated that developed a rash around her neck, armpits and under breast after receiving the vaccine. The rash lasted 2 to 3 days. The reporter also stated that she developed this rash when she becomes ill or gets other vaccines. The reporter states that she had the rash tested by a Dermatologists and it was determined that the rash was not an allergic reaction. The batch number was not provided and a request for this information has been made.